Johnny Huard, PhD, will present on The Future of Orthobiologics as an Adjuvant to Surgical Treatment. Geriatric syndromes could lead individuals to exhibit significant mobility and psychological deficits resulting in substantial healthcare costs. Thus, identifying strategies to delay aging or prevent progressive loss of tissue homeostasis could dramatically restore the function and independence of millions of elderly patients and significantly improve quality of life. Orthobiologics are innovative treatment adjuvants that are increasingly being used in the treatment of orthopedic injuries. The treatment can be administered to augment the biology or healing potential of the injured musculoskeletal tissue.

Speaker Bio:

Dr. Huard is the Chief Scientific Officer and Director of Linda & Mitch Hart Center for Regenerative & Personalized Medicine at Steadman Philippon Research Institute (SPRI), Vail, Colorado. Dr. Huard also holds Professor of Surgery position at the Duquesne University, Affiliate Faculty position at Colorado State University, Orthopaedic Surgery at the University of Miami and University of Pittsburgh. Dr. Huard was Professor, Distinguished Chair in the Department of Orthopaedic Surgery at the University of Texas Health Science Center (2015-2019). Dr. Huard held Henry J. Mankin Endowed Chair in the Department of Orthopaedic Surgery and was Director of the Stem Cell Research Center at the University of Pittsburgh (1995-2015).